[1]张文娟,郭永泽,程丽敏,等.miR-106b-3p和miR-214在食管鳞癌组织中的表达及其与临床病理特征的关系[J].医学信息,2021,34(03):116-119.[doi:10.3969/j.issn.1006-1959.2021.03.032]
 ZHANG Wen-juan,GUO Yong-ze,CHENG Li-min,et al.The Epression of miR-106b-3p and miR-214 in Esophageal Squamous Cell Carcinoma and Its Relationship with Clinicopathological Characteristics[J].Medical Information,2021,34(03):116-119.[doi:10.3969/j.issn.1006-1959.2021.03.032]
点击复制

miR-106b-3p和miR-214在食管鳞癌组织中的表达及其与临床病理特征的关系()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年03期
页码:
116-119
栏目:
论著
出版日期:
2021-02-01

文章信息/Info

Title:
The Epression of miR-106b-3p and miR-214 in Esophageal Squamous Cell Carcinoma and Its Relationship with Clinicopathological Characteristics
文章编号:
1006-1959(2021)03-0116-04
作者:
张文娟郭永泽程丽敏
(1.邯郸市第一医院消化科,河北 邯郸 056002; 2.河北工程大学附属医院消化科,河北 邯郸 056002; 3.邯郸市中心医院消化科,河北 邯郸 056000; 4.魏县人民医院消化科,河北 魏县 056800; 5.邯郸市第一医院胸外科,河北 邯郸 056002)
Author(s):
ZHANG Wen-juanGUO Yong-zeCHENG Li-minet al.
(1.Department of Gastroenterology,Handan First Hospital,Handan 056002,Hebei,China; 2.Department of Gastroenterology,the Affiliated Hospital of Hebei University of Engineering,Handan 056002,Hebei,China; 3.Department of Gastroenterology,Handan Central Hospi
关键词:
食管鳞癌miR-106b-3pmiR-214病理特征
Keywords:
Esophageal squamous cell carcinomamiR-106b-3pmiR-214Pathological features
分类号:
R735.1
DOI:
10.3969/j.issn.1006-1959.2021.03.032
文献标志码:
A
摘要:
目的 探讨miR-106b-3p和miR-214在食管鳞癌(ESCC)组织中的表达,分析其与患者临床病理特征的关系。方法 选取2016年10月~2018年8月邯郸市第一医院确诊的行外科手术切除的ESCC患者60例,取其切除癌组织标本及癌旁组织标本,采用RT-qPCR技术检测ESCC患者癌组织和癌旁组织中miR-106b-3p及miR-214的表达水平,比较两者在癌组织和癌旁组织的表达差异,分析其与患者临床病理特征的关系及诊断ESCC的诊断。结果 ESCC癌组织中miR-106b-3p和miR-214的表达量均高于癌旁组织,差异有统计学意义(P<0.05);不同淋巴结转移情况、肿瘤TNM分期的ESCC患者癌组织中miR-106b-3p、miR-214的表达比较,差异有统计学意义(P<0.05),不同年龄、性别的ESCC患者癌组织中miR-106b-3p、miR-214的表达比较,差异无统计学意义(P>0.05);ROC曲线显示,miR-106b-3p和miR-214诊断ESCC的敏感性分别为87.50%、85.00%,特异性分别为81.30%、87.50%。结论 miR-106b-3p和miR-214在食管鳞癌组织中表达上调,可作为致癌基因参与食管鳞癌的发生发展,且两者对诊断该病具有一定的价值。
Abstract:
Objective To explore the expression of miR-106b-3p and miR-214 in esophageal squamous cell carcinoma (ESCC) tissues, and analyze their relationship with the clinical pathological characteristics of patients.Methods A total of 60 ESCC patients diagnosed with surgical resection in Handan First Hospital from October 2016 to August 2018 were selected, and their cancerous tissue specimens and para-cancerous tissue specimens were collected.RT-qPCR technology was used to detect the expression levels of miR-106b-3p and miR-214 in cancer tissues and adjacent tissues of ESCC patients.Compare the expression differences between the two in cancer tissues and adjacent tissues, analyze their relationship with the clinical pathological characteristics of patients, and diagnose ESCC.Results The expressions of miR-106b-3p and miR-214 in ESCC cancer tissues were higher than those in adjacent tissues,the difference was statistically significant (P<0.05);Comparison of the expression of miR-106b-3p and miR-214 in cancer tissues of ESCC patients with different lymph node metastasis and tumor TNM staging,the difference was statistically significant (P<0.05),There was no statistically significant difference in the expression of miR-106b-3p and miR-214 in ESCC patients of different ages and genders (P>0.05);The ROC curve showed that the sensitivity of miR-106b-3p and miR-214 in diagnosing ESCC were 87.50% and 85.00%, and the specificity was 81.30% and 87.50%, respectively.Conclusion miR-106b-3p and miR-214 are up-regulated in esophageal squamous cell carcinoma tissues, and can be used as oncogenes to participate in the occurrence and development of esophageal squamous cell carcinoma, and both have certain value in the diagnosis of the disease.

参考文献/References:

[1]Torre LA,Bray F,Siegel R L,et al.Global cancer statistics,2012[J].CA,2015,65(2):87-108. [2]Rong L,Liu Y,Hui Z,et al.PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population[J].Diagnostic Pathology,2019,14(1):6. [3]Siegel RL,Miller KD,Jemal A.Cancer statistics,2015[J].CA,2015,65(1):5-29. [4]Ghafouri-Fard S,Shoorei H,Dashti S,et al.Expression profile of lncRNAs and miRNAs in esophageal cancer:Implications in diagnosis,prognosis,and therapeutic response[J].Journal of Cellular Physiology,2020,235(12):9269-9290. [5]Karbasforooshan H,Hayes AW,Mohammadzadeh N,et al.The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy[J].Cell Cycle,2020,19(23):3209-3221. [6]Rong L,Xia P,Chang JY,et al.MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer[J].PLoS One,2016,11(3):e0150467. [7]Zhai W,Li S,Zhang J,et al.Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals[J].Mol Cancer,2018,17(1):157. [8]Choi N,Park J,Lee JS,et al.miR-93/miR-106b/miR-375-CIC-CRABP1:a novel regulatory axis in prostate cancer progression[J].Oncotarget,2015,6(27) :23533-23547. [9]Shi BM,Lu W,Ji K,et al.Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma[J].World J Gastroenterol,2017,23(20):3713-3720. [10]Gong C,Qu S,Liu B,et al.MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells[J].Oncogene,2015:34(1):84-93. [11]Okumura T,Kojima H,Miwa T,et al.The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma[J].World Journal of Surgical Oncology,2016,14(1):228. [12] Zhang J,Chen D,Liang S,et al.miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC[J].Oncol Lett,2018,15(4):4619-4626. [13]肖长艳,郭子健,曹磊,等.Mir-106b表达与食管鳞状细胞癌的关系[J].南方医科大学学报,2016,36(12):1667-1671. [14]Zhang J,Chen D,Liang S,et al.miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC[J].Oncol Lett,2018,15(4):4619-4626. [15]Sharma T,Hamilton R,Mandal CC.miR-214:a potential biomarker and therapeutic for different cancers[J].Future oncology(London,England),2015,11(2):349-363. [16]Hao M,Zang M,Zhao L,et al.Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis[J].Oncotarget,2016,7(15):19589-19600. [17]Wang M,Wang L,Zhang M,et al.MiR-214 inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by targeting CDC25B[J].Biomedecine&Pharmacotherapie,2017(95):1678-1683.

相似文献/References:

[1]杨雅娟,李 静,朱 琳,等.食管鳞癌组织中miRNAs差异表达谱的筛选及研究[J].医学信息,2019,32(20):63.[doi:10.3969/j.issn.1006-1959.2019.20.018]
 YANG Ya-juan,LI Jing,ZHU Lin,et al.Screening and Study of Differential Expression Profiles of miRNAs in Esophageal Squamous Cell Carcinoma[J].Medical Information,2019,32(03):63.[doi:10.3969/j.issn.1006-1959.2019.20.018]
[2]李清河,廖玲玲,汪红艳.凝血指标对食管鳞癌预后的影响因素分析[J].医学信息,2021,34(24):33.[doi:10.3969/j.issn.1006-1959.2021.24.007]
 LI Qing-he,LIAO Ling-ling,WANG Hong-yan.Analysis of Influencing Factors of Coagulation Indexes on Prognosis of Esophageal Squamous Cell Carcinoma[J].Medical Information,2021,34(03):33.[doi:10.3969/j.issn.1006-1959.2021.24.007]
[3]左 磊,梅新宇,吴汉然.术前颈部淋巴结超声评估食管癌选择性三野清扫术的价值[J].医学信息,2021,34(14):87.[doi:10.3969/j.issn.1006-1959.2021.14.024]
 ZUO Lei,MEI Xin-yu,WU Han-ran.The Value of Preoperative Cervical Lymph Node Ultrasonography in Evaluating the Value of Selective Three-field Dissection for Esophageal Cancer[J].Medical Information,2021,34(03):87.[doi:10.3969/j.issn.1006-1959.2021.14.024]

更新日期/Last Update: 1900-01-01